BayWa Faces a Pivotal Month as Asset Sales Falter and Legal Woes Deepen

April is shaping up to be a defining moment for BayWa. The heavily indebted agricultural conglomerate is racing to secure a three-digit million-euro injection from a partial asset sale by the end of the month — cash it desperately needs to keep its restructuring plan alive. The shares, trading at €14.35, have shed roughly 14% since the start of the year, reflecting the market’s deepening unease.

The T&G Sale Stalls

A cornerstone of the rescue effort is the sale of a majority stake in T&G Global, BayWa’s New Zealand-based fruit subsidiary. Goldman Sachs has been running the process since March, marketing T&G’s globally recognized apple brands as a valuable asset. But the sale is proving sluggish. An Asian minority shareholder is complicating negotiations, and analysts estimate the proceeds will land at around €300 million — a fraction of what’s needed.

That sum barely scratches the surface. BayWa must shed €4 billion in debt by 2028, and roughly €2.7 billion of that target remains unaddressed. The company has already scrapped its 2026 profit forecast and slashed its 2027 EBITDA target to €140 million.

The Banks Hold the Cards

The real power play will unfold in the coming weeks. DZ Bank and HVB are voting on whether to extend the standstill agreement that underpins BayWa’s restructuring plan under the German StaRUG framework. If the core lenders refuse, the entire plan collapses. If they agree, management buys precious time to push through further measures.

The price of that extension will be painful. A debt haircut is now seen as all but inevitable. Particularly exposed are Bavarian cooperative banks, which hold around €200 million in Schuldschein loans. They already wrote down more than half of that exposure last year, and their association is now recommending additional provisioning.

Should investors sell immediately? Or is it worth buying BayWa?

Legal Fallout Mounts

While the financial clock ticks, BayWa is fending off a barrage of legal attacks. The Munich public prosecutor’s office is investigating two former CEOs on suspicion of breach of trust, including Klaus Josef Lutz, the architect of the credit-fueled expansion strategy. Current management is examining whether his multi-million-euro severance package can be clawed back. All suspects are presumed innocent.

The legal storm has been amplified by a formal reprimand from the financial regulator BaFin. BayWa failed to disclose material details about a billion-euro loan and refinancing risks tied to a €500 million bond in its 2023 management report. That omission has opened the door to shareholder lawsuits. The Tübingen-based law firm TILP is organizing claims for anyone who bought shares between January 2022 and January 2026 — a period covering a significant chunk of the shareholder base.

The auditor fallout is equally damaging. PricewaterhouseCoopers signed off on the flawed 2023 accounts without qualification, drawing scrutiny from the audit oversight body Apas. BayWa has ended its relationship with PwC and is exploring damages claims. The result: a certified 2025 annual report won’t appear until late 2026 at the earliest, leaving investors flying blind.

Governance Tightens

The supervisory board is shrinking. Monika Hohlmeier and Michael Höllerer resigned at the end of March, and Monique Surges will follow at the end of May. In a clear signal of tighter internal controls, the threshold for board-approval on transactions has been cut from €200 million to €50 million.

BayWa plans to cut 1,300 jobs by 2028 and refocus on a handful of core businesses. But with no reliable financial data in sight and the bank vote looming, the next hard move in the stock — currently trading 14% below its 200-day average — will likely come from the lenders’ decision, not the company’s own efforts.